Andrew J Solomon1, Richard Watts2, Daniel Ontaneda3, Martina Absinta4, Pascal Sati4, Daniel S Reich4. 1. Department of Neurological Sciences, Larner College of Medicine, The University of Vermont, Burlington, VT, USA. 2. Department of Radiology, Larner College of Medicine, The University of Vermont, Burlington, VT, USA. 3. Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA. 4. Translational Neuroradiology Section, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Abstract
BACKGROUND: Detection of a "central vein sign" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis (MS). We evaluated the specificity and sensitivity of simplified CVS algorithms for MS diagnosis. METHODS: MRIs from 10 participants with MS without additional comorbidities for MRI white matter abnormalities; 10 with MS and additional comorbidities for white matter abnormalities; 10 with migraine, white matter abnormalities, and no additional comorbidities; and 10 who had previously been erroneously diagnosed with MS were evaluated. 3T MRI T2-FLAIR and T2*-weighted sequences were acquired to create FLAIR* images. Three MS physician reviewers, blinded to diagnosis, evaluated two different algorithms: (1) three lesions pre-selected on FLAIR were subsequently evaluated for CVS on FLAIR*( select3). (2) FLAIR* was evaluated for up to three lesions with CVS ( select3*). RESULTS: For select3, average specificity across reviewers for MS was 0.98 and sensitivity 0.52 and a correct prediction of diagnosis demonstrated kappa = 0.29. For select3*, specificity was 0.81, sensitivity was 0.83, and kappa was 0.31. CONCLUSION: A simplified determination of CVS in three white matter lesions on 3T FLAIR* MRI demonstrated good specificity and sensitivity and fair inter-rater reliability for a diagnosis of MS and with further study, may be a candidate for clinical application.
BACKGROUND: Detection of a "central vein sign" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis (MS). We evaluated the specificity and sensitivity of simplified CVS algorithms for MS diagnosis. METHODS: MRIs from 10 participants with MS without additional comorbidities for MRI white matter abnormalities; 10 with MS and additional comorbidities for white matter abnormalities; 10 with migraine, white matter abnormalities, and no additional comorbidities; and 10 who had previously been erroneously diagnosed with MS were evaluated. 3T MRI T2-FLAIR and T2*-weighted sequences were acquired to create FLAIR* images. Three MS physician reviewers, blinded to diagnosis, evaluated two different algorithms: (1) three lesions pre-selected on FLAIR were subsequently evaluated for CVS on FLAIR*( select3). (2) FLAIR* was evaluated for up to three lesions with CVS ( select3*). RESULTS: For select3, average specificity across reviewers for MS was 0.98 and sensitivity 0.52 and a correct prediction of diagnosis demonstrated kappa = 0.29. For select3*, specificity was 0.81, sensitivity was 0.83, and kappa was 0.31. CONCLUSION: A simplified determination of CVS in three white matter lesions on 3T FLAIR* MRI demonstrated good specificity and sensitivity and fair inter-rater reliability for a diagnosis of MS and with further study, may be a candidate for clinical application.
Authors: Andrew J Solomon; Dennis N Bourdette; Anne H Cross; Angela Applebee; Philip M Skidd; Diantha B Howard; Rebecca I Spain; Michelle H Cameron; Edward Kim; Michele K Mass; Vijayshree Yadav; Ruth H Whitham; Erin E Longbrake; Robert T Naismith; Gregory F Wu; Becky J Parks; Dean M Wingerchuk; Brian L Rabin; Michel Toledano; W Oliver Tobin; Orhun H Kantarci; Jonathan L Carter; B Mark Keegan; Brian G Weinshenker Journal: Neurology Date: 2016-08-31 Impact factor: 9.910
Authors: Pascal Sati; Jiwon Oh; R Todd Constable; Nikos Evangelou; Charles R G Guttmann; Roland G Henry; Eric C Klawiter; Caterina Mainero; Luca Massacesi; Henry McFarland; Flavia Nelson; Daniel Ontaneda; Alexander Rauscher; William D Rooney; Amal P R Samaraweera; Russell T Shinohara; Raymond A Sobel; Andrew J Solomon; Constantina A Treaba; Jens Wuerfel; Robert Zivadinov; Nancy L Sicotte; Daniel Pelletier; Daniel S Reich Journal: Nat Rev Neurol Date: 2016-11-11 Impact factor: 42.937
Authors: Sarah-Michelle Orton; Blanca M Herrera; Irene M Yee; William Valdar; Sreeram V Ramagopalan; A Dessa Sadovnick; George C Ebers Journal: Lancet Neurol Date: 2006-11 Impact factor: 44.182
Authors: Amal P R Samaraweera; Margareta A Clarke; Amy Whitehead; Yasser Falah; Ian D Driver; Robert A Dineen; Paul S Morgan; Nikos Evangelou Journal: J Neuroimaging Date: 2016-06-14 Impact factor: 2.486
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Andrew J Solomon; Matthew K Schindler; Diantha B Howard; Richard Watts; Pascal Sati; Joshua P Nickerson; Daniel S Reich Journal: Ann Clin Transl Neurol Date: 2015-12-16 Impact factor: 4.511
Authors: J D Dworkin; P Sati; A Solomon; D L Pham; R Watts; M L Martin; D Ontaneda; M K Schindler; D S Reich; R T Shinohara Journal: AJNR Am J Neuroradiol Date: 2018-09-13 Impact factor: 3.825
Authors: Pietro Maggi; Martina Absinta; Pascal Sati; Gaetano Perrotta; Luca Massacesi; Bernard Dachy; Caroline Pot; Reto Meuli; Daniel S Reich; Massimo Filippi; Renaud Du Pasquier; Marie Théaudin Journal: Mult Scler Date: 2019-09-19 Impact factor: 6.312
Authors: M A Clarke; D Pareto; L Pessini-Ferreira; G Arrambide; M Alberich; F Crescenzo; S Cappelle; M Tintoré; J Sastre-Garriga; C Auger; X Montalban; N Evangelou; À Rovira Journal: AJNR Am J Neuroradiol Date: 2020-05-21 Impact factor: 3.825
Authors: S Suthiphosuwan; P Sati; M Guenette; X Montalban; D S Reich; A Bharatha; J Oh Journal: AJNR Am J Neuroradiol Date: 2019-04-18 Impact factor: 3.825
Authors: Omar Al-Louzi; Sargis Manukyan; Maxime Donadieu; Martina Absinta; Vijay Letchuman; Brent Calabresi; Parth Desai; Erin S Beck; Snehashis Roy; Joan Ohayon; Dzung L Pham; Anish Thomas; Steven Jacobson; Irene Cortese; Pavan K Auluck; Govind Nair; Pascal Sati; Daniel S Reich Journal: Mult Scler Date: 2022-06-08 Impact factor: 5.855
Authors: Refaat E Gabr; Amol S Pednekar; Arash Kamali; John A Lincoln; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana Journal: Magn Reson Med Date: 2018-01-15 Impact factor: 4.668
Authors: Jordan D Dworkin; Kristin A Linn; Andrew J Solomon; Theodore D Satterthwaite; Armin Raznahan; Rohit Bakshi; Russell T Shinohara Journal: Biostatistics Date: 2021-07-17 Impact factor: 5.899
Authors: Pietro Maggi; Mário João Fartaria; João Jorge; Francesco La Rosa; Martina Absinta; Pascal Sati; Reto Meuli; Renaud Du Pasquier; Daniel S Reich; Meritxell Bach Cuadra; Cristina Granziera; Jonas Richiardi; Tobias Kober Journal: NMR Biomed Date: 2020-03-03 Impact factor: 4.478